General Information of the Compound
Compound ID
CP0536368
Compound Name
(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine
    Show/Hide
Structure
Formula
C19H24FN5O
Molecular Weight
357.433
Canonical SMILES
O\N=C(\CCCN1CCCN(CC1)c1ncccn1)c1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C19H24FN5O/c20-17-7-5-16(6-8-17)18(23-26)4-1-11-24-12-3-13-25(15-14-24)19-21-9-2-10-22-19/h2,5-10,26H,1,3-4,11-15H2/b23-18-
    Show/Hide
InChIKey
NBTOXXDFQOHTRO-NKFKGCMQSA-N
Physicochemical Property
logP
2.7865
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
64.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155556295
ChEMBL ID
CHEMBL4554850
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 148 nM
   TI
   LI
   LO
   TS